Authors:
ALTMAN LC
MUNK Z
SELTZER J
NOONAN N
SHINGO S
ZHANG J
REISS TF
Citation: Lc. Altman et al., A PLACEBO-CONTROLLED, DOSE-RANGING STUDY OF MONTELUKAST, A CYSTEINYL LEUKOTRIENE-RECEPTOR ANTAGONIST, Journal of allergy and clinical immunology, 102(1), 1998, pp. 50-56
Authors:
MULLIGAN ED
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, Gastroenterology, 114(4), 1998, pp. 2673-2673
Authors:
MULLIGAN ED
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA DOES NOT INCREASE POSTOPERATIVE MORBIDITY OR MORTALITY, Gastroenterology, 114(4), 1998, pp. 2674-2674
Authors:
MULLIGAN ED
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., CLINICOPATHOLOGICAL FACTORS IN THE RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, Gastroenterology, 114(4), 1998, pp. 2675-2675
Authors:
MULLIGAN ED
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., THE IMPORTANCE OF NEGATIVE MICROSCOPY MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, Gastroenterology, 114(4), 1998, pp. 2676-2676
Authors:
MULLIGAN ED
WALSH TN
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., IMPORTANCE OF NEGATIVE MICROSCOPIC MARGINS IN THE MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER, British Journal of Surgery, 85(5), 1998, pp. 695-695
Authors:
MULLIGAN ED
WALSH TN
DUNNE B
PURCELL T
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., TUMOR LENGTH PREDICTS RESPONSE TO NEOADJUVANT CHEMORADIOTHERAPY IN ESOPHAGEAL ADENOCARCINOMA, British Journal of Surgery, 85(5), 1998, pp. 696-696
Authors:
MULLIGAN ED
PURCELL T
DUNNE B
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., ADJUNCTIVE CHEMORADIOTHERAPY IN ESOPHAGEAL-CARCINOMA - NO INCREASE INPOSTOPERATIVE MORBIDITY OR MORTALITY, British Journal of Surgery, 85, 1998, pp. 29-29
Authors:
MULLIGAN ED
PURCELL T
DUNNE B
GRIFFIN M
NOONAN N
HOLLYWOOD D
KEELING N
REYNOLDS JV
HENNESSY TPJ
Citation: Ed. Mulligan et al., ADENOCARCINOMA OF ESOPHAGUS JUNCTION AND CARDIA - SIMILAR RESPONSE TONEOADJUVANT THERAPY, British Journal of Surgery, 85, 1998, pp. 86-86
Authors:
FARRELL RJ
NOONAN N
KHAN IM
COGGINS M
KELLEHER DP
KEELING PWN
Citation: Rj. Farrell et al., CARCINOMA OF THE AMPULLA OF VATER - A TUMOR WITH A POOR-PROGNOSIS, European journal of gastroenterology & hepatology, 8(2), 1996, pp. 139-144
Authors:
CHENG HY
LEFF JA
AMIN R
GERTZ BJ
DESMET M
NOONAN N
ROGERS JD
MALBECQ W
MEISNER D
SOMERS G
Citation: Hy. Cheng et al., PHARMACOKINETICS, BIOAVAILABILITY, AND SAFETY OF MONTELUKAST SODIUM (MK-0476) IN HEALTHY-MALES AND FEMALES, Pharmaceutical research, 13(3), 1996, pp. 445-448
Authors:
WALSH TN
NOONAN N
HOLLYWOOD D
KELLY A
KEELING N
HENNESSY TPJ
Citation: Tn. Walsh et al., A COMPARISON OF MULTIMODAL THERAPY AND SURGERY FOR ESOPHAGEAL ADENOCARCINOMA, The New England journal of medicine, 335(7), 1996, pp. 462-467
Authors:
WALSH TN
NOONAN N
HOLLYWOOD D
KELLY A
KEELING PNW
HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODALITY THERAPY VERSUS SURGERY FOR ESOPHAGEAL ADENOCARCINOMA - A PROSPECTIVE RANDOMIZED TRIAL, Gastroenterology, 110(4), 1996, pp. 611-611
Authors:
PATTERSON KW
NOONAN N
KEELING NW
KIRKHAM R
HOGAN DF
Citation: Kw. Patterson et al., HYPOXEMIA DURING OUTPATIENT GASTROINTESTINAL ENDOSCOPY - THE EFFECTS OF SEDATION AND SUPPLEMENTAL OXYGEN, Journal of clinical anesthesia, 7(2), 1995, pp. 136-140
Authors:
WALSH TN
NOONAN N
HOLLYWOOD D
KEELING PWN
HENNESSY TPJ
Citation: Tn. Walsh et al., MULTIMODALITY TREATMENT PLUS SURGERY VERSUS SURGERY ALONE FOR ESOPHAGEAL ADENOCARCINOMA, Gastroenterology, 108(4), 1995, pp. 550-550